Astrazeneca buys early-stage U.S. biotech firm

Reuters

Astrazeneca said on Wednesday that its MedImmune unit has bought AlphaCore Pharma, a US-based biotechnology company focused on heart treatments.

Financial details of the acquisition were not disclosed.

Continue Reading Below

(Reporting by Brenda Goh, Editing by Christine Murray)